Luye Pharma Valuation
| LYPHF Stock | USD 0.34 0.00 0.00% |
Luye Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Luye Pharma Group from analyzing the firm fundamentals such as Current Valuation of 2.08 B, return on equity of -0.0261, and Profit Margin of (0.04) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Luye Pharma's price fluctuation is extremely dangerous at this time. Calculation of the real value of Luye Pharma Group is based on 3 months time horizon. Increasing Luye Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Luye pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Luye Pharma Group. Since Luye Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Luye Pink Sheet. However, Luye Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.34 | Real 0.28 | Hype 0.34 |
The real value of Luye Pink Sheet, also known as its intrinsic value, is the underlying worth of Luye Pharma Group Company, which is reflected in its stock price. It is based on Luye Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Luye Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Luye Pharma Group helps investors to forecast how Luye pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Luye Pharma more accurately as focusing exclusively on Luye Pharma's fundamentals will not take into account other important factors: Luye Pharma Total Value Analysis
Luye Pharma Group is now forecasted to have takeover price of 2.08 B with market capitalization of 2.66 B, debt of 4.21 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Luye Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.08 B | 2.66 B | 4.21 B |
Luye Pharma Investor Information
About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Luye Pharma was now reported as 2.54. The company last dividend was issued on the 29th of June 2020. Based on the key measurements obtained from Luye Pharma's financial statements, Luye Pharma Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Luye Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Luye implies not a very effective usage of assets in January.Luye Pharma Ownership Allocation
Luye Pharma Group maintains a total of 3.55 Billion outstanding shares. Luye Pharma Group holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Luye Pharma Profitability Analysis
The company reported the revenue of 5.2 B. Net Loss for the year was (134.39 M) with profit before overhead, payroll, taxes, and interest of 3.4 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Luye Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Luye Pharma and how it compares across the competition.
About Luye Pharma Valuation
The pink sheet valuation mechanism determines Luye Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Luye Pharma. We calculate exposure to Luye Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Luye Pharma's related companies.Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide. The company was founded in 1994 and is headquartered in Yantai, the Peoples Republic of China. Luye Pharma is traded on OTC Exchange in the United States.
8 Steps to conduct Luye Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Luye Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Luye Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Luye Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Luye Pharma's revenue streams: Identify Luye Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Luye Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Luye Pharma's growth potential: Evaluate Luye Pharma's management, business model, and growth potential.
- Determine Luye Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Luye Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Luye Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Luye Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.5 B | |
| Quarterly Earnings Growth Y O Y | -0.244 | |
| Forward Price Earnings | 20.4082 | |
| Retained Earnings | 6.1 B |
Complementary Tools for Luye Pink Sheet analysis
When running Luye Pharma's price analysis, check to measure Luye Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Luye Pharma is operating at the current time. Most of Luye Pharma's value examination focuses on studying past and present price action to predict the probability of Luye Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Luye Pharma's price. Additionally, you may evaluate how the addition of Luye Pharma to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |